Adverse events in patients with ankylosing spondylitis treated with TNF inhibitors: a cross-sectional study
Conclusion TNF inhibitors show a good safety profile in ankylosing spondylitis patients.
Source: International Journal of Clinical Pharmacy - Category: Drugs & Pharmacology Source Type: research
More News: Ankylosing Spondylitis | Arthritis | Drugs & Pharmacology | Electronic Medical Records (EMR) | Pain | Poland Health | Rheumatoid Arthritis | Rheumatology | Study